20.95000 EUR
0.845
3.88%
Last update Dec 18, 7:37 PM CET
Market closed
Day range
20.95000
21.66000
Previous close
21.79500
Open
21.375
Access this stock data via API
Subscribe
Apellis Pharmaceuticals Inc.
20.95
0.85
3.88%

Statistics

Valuation metrics
Market cap
0
Enterprise value
49.87M
Trailing P/E (ttm)
-13.09
Forward P/E
PEG ratio
Price/Sales (ttm)
0
Price/Book (mrq)
Enterprise Value/Revenue
0.07
Enterprise Value/EBITDA
-0.38
Overview
Shares outstanding
126.50M
Float
Shares short
% Held by insiders
% Held by institutions
Average volume (10 days)
5
Average volume (90 days)
2
Price summary
52-Week low
14.53
52-Week high
33.89
52-Week change
-53.82 -370.5%
Beta
50-Day moving average
20.03
200-Day moving average
19.00
Financials
Fiscal year
Fiscal year ends
Dec 31, 2024
Most recent quarter (mrq)
Sep 30, 2025
Profitability
Profit margin
84.93%
Operating margin
-20.01%
Operational effectiveness
Return on assets
-22.36%
Return on equity
-86.58%
Income statement
Revenue (ttm)
666.11M
Revenue per share (ttm)
6.31
Quarterly revenue growth (yoy)
156.92%
Gross profit (ttm)
565.75M
EBITDA
0
Net income to common (ttm)
-168.69M
Diluted EPS (ttm)
-1.60
Quarterly earnings growth (yoy)
129.75%
Balance sheet
Total cash (mrq)
0
Total cash per share (mrq)
Total debt (mrq)
405.25M
Total Debt/Equity (mrq)
1.18
Current ratio (mrq)
354.41%
Book value per share (mrq)
Cash flow
Cash flow statement
-109.45M
Levered free cash flow (LFCF)
-168.69M
Access /statistics data via our API — starting from the Pro plan.
Market closed

Exchange is currently closed
Main market opens in 52 minutes

07:07
00:00
08:00
20:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 20:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).